Nutralife Biosciences Stock Buy Hold or Sell Recommendation
| NLBS Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Nutralife Biosciences is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Nutralife Biosciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Nutralife Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Nutralife Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Nutralife and provide practical buy, sell, or hold advice based on investors' constraints. Nutralife Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Nutralife |
Execute Nutralife Biosciences Buy or Sell Advice
The Nutralife recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nutralife Biosciences. Macroaxis does not own or have any residual interests in Nutralife Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nutralife Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Nutralife Biosciences Trading Alerts and Improvement Suggestions
| Nutralife Biosciences generated a negative expected return over the last 90 days | |
| Nutralife Biosciences has some characteristics of a very speculative penny stock | |
| Nutralife Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Nutralife Biosciences currently holds 10 K in liabilities. Nutralife Biosciences has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutralife Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Nutralife Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutralife Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutralife to invest in growth at high rates of return. When we think about Nutralife Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 626.62 K. Net Loss for the year was (5.83 M) with profit before overhead, payroll, taxes, and interest of 83.59 K. | |
| Nutralife Biosciences currently holds about 51.8 K in cash with (487.39 K) of positive cash flow from operations. | |
| Roughly 46.0% of the company outstanding shares are owned by corporate insiders |
Nutralife Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nutralife Biosciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nutralife Biosciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nutralife pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Nutralife Biosciences Volatility Alert
At this time Nutralife Biosciences exhibits very low volatility. Nutralife Biosciences appears to be a penny stock. Although Nutralife Biosciences may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Nutralife Biosciences or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Nutralife instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Nutralife Biosciences Fundamentals Vs Peers
Comparing Nutralife Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nutralife Biosciences' direct or indirect competition across all of the common fundamentals between Nutralife Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nutralife Biosciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Nutralife Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Nutralife Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nutralife Biosciences to competition |
| Fundamentals | Nutralife Biosciences | Peer Average |
| Return On Equity | -14.26 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Operating Margin | (3.80) % | (5.51) % |
| Current Valuation | 11.61 M | 16.62 B |
| Shares Outstanding | 176.62 M | 571.82 M |
| Shares Owned By Insiders | 45.95 % | 10.09 % |
| Price To Book | 85.51 X | 9.51 X |
| Price To Sales | 14.09 X | 11.42 X |
| Revenue | 626.62 K | 9.43 B |
| Gross Profit | 83.59 K | 27.38 B |
| EBITDA | (5.71 M) | 3.9 B |
| Net Income | (5.83 M) | 570.98 M |
| Cash And Equivalents | 51.8 K | 2.7 B |
| Total Debt | 10 K | 5.32 B |
| Current Ratio | 0.10 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (487.39 K) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Number Of Employees | 12 | 18.84 K |
| Beta | -0.9 | -0.15 |
| Market Capitalization | 6.62 M | 19.03 B |
| Total Asset | 4.85 M | 29.47 B |
| Net Asset | 4.85 M |
Nutralife Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nutralife . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Nutralife Biosciences Buy or Sell Advice
When is the right time to buy or sell Nutralife Biosciences? Buying financial instruments such as Nutralife Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nutralife Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.